Wegovy and other GLP-1 weight loss medications have become widely used, but federal lawsuits now allege that some patients were not adequately warned about serious gastrointestinal and vision-related injuries
Athletes subject to WADA, USADA, NCAA, or other sport-governing-body testing should not use it
Hepatology (2002) doi:10.1053/jhep.2002.30692
4h,i and Supplementary Fig
Reading time: 5 min Author Published on Updated on Women's Health Get expert guidance and a personalized care plan designed around you
Because they both target the GLP-1 receptor and have long half-lives, taking them together can lead to an overdose effect, resulting in severe nausea, vomiting, and potential dehydration